Can I Take Berberine with Low-Dose Naltrexone?
A clinical review of the berberine and low-dose naltrexone interaction, covering pharmacokinetics, CYP3A4 inhibition, glucose effects, dosing timing, and safety monitoring for patients using both.
A clinical review of the berberine and low-dose naltrexone interaction, covering pharmacokinetics, CYP3A4 inhibition, glucose effects, dosing timing, and safety monitoring for patients using both.
A guide on the calcium and low-dose naltrexone interaction: what the evidence shows, whether dose separation is needed, monitoring tips, and who should exercise extra caution.
A guide to the ginseng and low-dose naltrexone interaction, covering pharmacokinetics, blood sugar effects, anticoagulation risk, monitoring protocols, and when to separate doses.
A guide to combining glutathione supplementation with compounded low-dose naltrexone (LDN). Covers pharmacokinetic interactions, liver detox pathways, dosing windows, and safety monitoring.
A guide covering the hepatotoxicity risk, CYP3A4 interactions, and safe-use protocol for combining green tea extract (EGCG) with compounded low-dose naltrexone (LDN).
A guide covering the pharmacokinetic and pharmacodynamic interaction between L-theanine and compounded low-dose naltrexone (LDN), including safety data, dosing windows, and monitoring guidance.
A guide to combining magnesium supplements with low-dose naltrexone (LDN): pharmacokinetic interactions, timing, dosing, monitoring, and safety evidence for patients with fibromyalgia, autoimmune disease, and chronic inflammation.
Melatonin with low-dose naltrexone: dose timing, vivid dreams, sleep outcomes, other medication interactions and glucose questions explained with primary studies.
A guide covering the pharmacokinetic and pharmacodynamic interaction between NAC and low-dose naltrexone (LDN), including dosing, timing, monitoring, and safety evidence.
A clinical review of the safety, pharmacology, and monitoring considerations for combining omega-3 fatty acids (EPA/DHA) with low-dose naltrexone (LDN), including interaction type, dose guidance, and what to watch for.
A detailed clinical review of the quercetin and low-dose naltrexone interaction, covering CYP3A4 pharmacokinetics, opioid receptor pharmacodynamics, dose-separation strategies, and monitoring guidance.
A guide to the reishi mushroom and low-dose naltrexone interaction, covering pharmacokinetic and pharmacodynamic mechanisms, safety signals, monitoring recommendations, and practical dosing guidance.
A guide to the pharmacokinetic and pharmacodynamic interaction between resveratrol and low-dose naltrexone (LDN), including CYP3A4 overlap, estrogenic effects, dosing guidance, and monitoring recommendations.
A cautious clinical review of what is known, what is plausible, and what remains unverified about combining rhodiola rosea with compounded low-dose naltrexone (LDN).
A guide covering the pharmacokinetic and pharmacodynamic interactions between saw palmetto and compounded low-dose naltrexone (LDN), including safety, monitoring, and dosing guidance.
A guide covering the safety, mechanism, and practical co-administration of vitamin B12 with compounded low-dose naltrexone (LDN), including monitoring guidance and dosing considerations.
A guide to the zinc and low-dose naltrexone interaction: pharmacokinetics, immune effects, copper balance, dosing windows, and monitoring.
A guide to the metformin and alpha-lipoic acid combination: interaction mechanisms, hypoglycemia risk, dosing, timing, and what monitoring your doctor should order.
A guide to the metformin and calcium interaction: pharmacokinetics, timing, B12 implications, dosing, and safety monitoring for people with type 2 diabetes or prediabetes.
Creatine and metformin are generally safe together with normal kidney function; creatine raises serum creatinine, so tell your prescriber before starting.
A guide covering the pharmacokinetic and pharmacodynamic interactions between green tea extract (EGCG) and metformin, including hepatotoxicity risk, dosing windows, and monitoring recommendations.
A guide to the lion's mane and metformin interaction: mechanisms, safety evidence, monitoring parameters, and practical dosing guidance for people with type 2 diabetes or prediabetes.
Metformin and magnesium citrate are generally safe together: no FDA contraindication listed. Separate doses by 2 hours and start at 200 mg elemental daily.
A guide to the melatonin-metformin interaction: mechanism, glucose effects, safe dosing windows, and monitoring steps for people with type 2 diabetes or prediabetes.
A guide to the NAC and metformin combination: pharmacokinetic and pharmacodynamic interactions, evidence from key trials, safety monitoring, and practical dosing guidance.
A clinical review of the reishi mushroom and Metformin interaction: mechanism, blood sugar effects, anticoagulant risk, monitoring, and what to do if you are already taking both.
A guide to the metformin-rhodiola interaction: mechanisms, blood glucose effects, serotonergic concerns, monitoring, and practical dosing guidance for patients on both.
A guide to the St. John's Wort and metformin interaction: mechanism, blood sugar effects, monitoring, and what to do if you take both.
A guide covering the pharmacokinetic and pharmacodynamic interactions between turmeric (curcumin) and metformin, including dosing considerations, monitoring, and safety evidence.
A guide covering the safety, interactions, and dosing considerations of combining vitamin B6 with metformin for type 2 diabetes or prediabetes management.
A guide covering the safety, interactions, monitoring, and dosing of vitamin B12 combined with methimazole (Tapazole) for hyperthyroidism and Graves disease.
A guide to the pharmacodynamic interaction between MK-677 (Ibutamoren) and alpha-lipoic acid, covering hypoglycemia risk, thyroid hormone effects, dosing windows, and monitoring protocols.
Berberine and ibutamoren evidence, distinguishing measured CYP and glucose findings from untested exposure, risk-offset, timing, and safety claims.
A guide to the calcium and MK-677 (ibutamoren) interaction: pharmacokinetics, absorption timing, IGF-1 and bone effects, cardiovascular monitoring, and clinical recommendations.
A clinical review of the ginseng and MK-677 (Ibutamoren) interaction, covering glucose effects, anticoagulant risk, monitoring, and what to do if you are already taking both.
A guide to combining glycine with MK-677 (Ibutamoren): mechanisms, pharmacodynamic interactions, dosing windows, glycemic monitoring, and what the clinical evidence actually shows.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between green tea extract (EGCG) and MK-677 (Ibutamoren), including hepatotoxicity risk, CYP enzyme overlap, dosing windows, and monitoring guidance.
A clinical review of the interaction between reishi mushroom and MK-677 (Ibutamoren), covering mechanism, pharmacokinetics, immune modulation, anticoagulant risk, dosing strategy, and monitoring guidance.
A breakdown of the turmeric/curcumin and MK-677 (Ibutamoren) interaction: pharmacokinetics, pharmacodynamics, bleeding risk, CYP3A4 overlap, dose timing, and monitoring guidance.
A guide to combining vitamin B12 with MK-677 (Ibutamoren): pharmacokinetic interactions, depletion risks, dosing strategy, and monitoring recommendations backed by primary literature.
A guide covering the pharmacokinetic and pharmacodynamic interaction between vitamin B6 and MK-677 (ibutamoren), including safe dosing ranges, neuropathy risk, and monitoring recommendations.
A guide covering the MK-677 and zinc interaction, mechanism, dosing windows, copper balance, GH/IGF-1 effects, and monitoring recommendations for anyone combining ibutamoren with zinc supplementation.
A guide to combining caffeine with MOTS-c mitochondrial peptide: pharmacokinetic and pharmacodynamic interactions, glucose effects, blood pressure risks, dose-separation windows, and monitoring protocols.
A guide to combining CoQ10 with the MOTS-c mitochondrial peptide: mechanism overlap, pharmacodynamic interactions, statin considerations, and practical dosing protocols.
Folate and MOTS-c evidence separating cell-model one-carbon metabolism, clinical interaction data, MTHFR myths, and established folate guidance.
Explore how MOTS-c signaling differs from glutathione biology and why laboratory findings do not establish a combined injection protocol or recovery benefit.
A source-led review of MOTS-c with magnesium, separating established magnesium evidence from the missing administered-human MOTS-c interaction data.
A guide to combining melatonin with MOTS-c peptide: mechanism overlap, pharmacodynamic interactions, dosing windows, glucose monitoring, and safety evidence.
A thorough clinical review of combining N-acetylcysteine (NAC) with the mitochondrial peptide MOTS-c, covering mechanisms, potential pharmacodynamic interactions, dosing timing, and monitoring guidance.
A guide to combining reishi mushroom with MOTS-c peptide: pharmacodynamic interactions, immune and coagulation considerations, dosing windows, monitoring parameters, and when to avoid the combination entirely.
A guide to combining saw palmetto with MOTS-c peptide therapy, covering mechanisms, pharmacodynamic interactions, dosing timing, and safety monitoring.
A clinical review of combining MOTS-c mitochondrial peptide with turmeric or curcumin supplements, covering pharmacodynamic interactions, anti-inflammatory overlap, mild anticoagulant risk, and practical dosing guidance.
A guide covering whether vitamin B6 is safe to take with MOTS-c peptide, how they interact mechanistically, what doses matter, and what monitoring looks like in practice.
A guide to caffeine and Mounjaro (tirzepatide) interactions: pharmacokinetics, blood sugar effects, blood pressure, safe intake limits, and monitoring.
Learn whether CoQ10 is safe to take with Mounjaro (tirzepatide), how the two interact pharmacologically, who benefits most from adding CoQ10, and practical dosing guidance prepared by the HealthRX.com Editorial Team.
A complete clinical review of folate supplementation alongside tirzepatide (Mounjaro), covering interaction mechanisms, safety evidence, MTHFR considerations, dosing guidance, and monitoring recommendations.
A guide to combining glycine supplements with Mounjaro (tirzepatide), covering mechanism, plausible glycemic overlap, sleep dosing, and what remains unverified.
A clinical review of the NAC and Mounjaro (tirzepatide) combination: known interactions, mechanisms, safety data, PCOS context, and practical dosing guidance from the HealthRX.com medical team.
A detailed clinical review of the reishi mushroom and Mounjaro (tirzepatide) interaction, covering pharmacokinetics, immune effects, bleeding risk, monitoring, and practical guidance for patients.
A board-reviewed guide on the safety, pharmacology, and monitoring considerations of combining saw palmetto with Mounjaro (tirzepatide) for diabetes or weight loss.

LegitScript certification
Verify HealthRX.comHealthRX.com is a platform connecting patients with independent licensed healthcare providers and pharmacies. Those providers deliver medical care and pharmacies dispense medication. Prescriptions are issued only when clinically appropriate. Payment does not guarantee a prescription.
Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Individual results vary.
Website information is educational and is not a substitute for personalized medical advice, diagnosis, or treatment. Consult your licensed healthcare provider.